Chiesi Ventures: A US-based venture capital firm investing in early-stage healthcare, focusing on rare disorders.
Location
Boston, MA, US
Founded
2014
Chiesi Ventures is a US-based venture capital firm specializing in early-stage investments within the healthcare sector, with a particular focus on rare and orphan disorders. The firm typically participates in Series A, Series B, and occasionally Series C funding rounds, aligning its investments to complement the strategic interests of the Chiesi Group.
Notable portfolio companies include 4D Molecular Therapeutics, CuraSen Therapeutics, Glycomine, Kezar Life Sciences, Mirum Pharmaceuticals, Sentien Biotechnologies, Sentieon, and VelosBio. Chiesi Ventures engages deeply with the scientific community, industry stakeholders, and regulators to navigate the complexities of developing cures for rare diseases. Their investment philosophy centers on fostering innovation and accelerating diagnosis and treatment for rare conditions.
Chiesi Ventures - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
